The depletion of CD4+CD25+Foxp3high Treg cells increases the efficacy of vaccination approaches that are aimed at increasing cellular and humoral immunity to Her-2 which is expressed on primary and metastasized breast cancer cells. The gene discussed is ERBB2; the disease is breast cancer.